Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.

Fazio VM, Ria F, Franco E, Rosati P, Cannelli G, Signori E, Parrella P, Zaratti L, Iannace E, Monego G, Blogna S, Fioretti D, Iurescia S, Filippetti R, Rinaldi M.

Gene Ther. 2004 Mar;11(6):544-51.

PMID:
14999226
2.

Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety.

Rinaldi M, Signori E, Rosati P, Cannelli G, Parrella P, Iannace E, Monego G, Ciafrè SA, Farace MG, Iurescia S, Fioretti D, Rasi G, Fazio VM.

Vaccine. 2006 May 22;24(21):4586-91. Epub 2005 Aug 24.

PMID:
16154671
3.

DNA vaccination in utero: a new approach to induce protective immunity in the newborn.

Gerdts V, Tsang C, Griebel PJ, Babiuk LA.

Vaccine. 2004 Apr 16;22(13-14):1717-27.

PMID:
15068855
4.

Hepatitis B immunization in low birthweight infants: do they need an additional dose?

Arora NK, Ganguly S, Agadi SN, Irshad M, Kohli R, Deo M, Paul VK, Deorari AK, Chellani H, Prasad MS, Sharma D.

Acta Paediatr. 2002;91(9):995-1001.

PMID:
12412879
5.

Fetal immunization of baboons induces a fetal-specific antibody response.

Watts AM, Stanley JR, Shearer MH, Hefty PS, Kennedy RC.

Nat Med. 1999 Apr;5(4):427-30.

PMID:
10202933
6.

Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.

Zhang Y, Jiang W, Fan Y, Wen J, Hao W, Qian M.

J Virol Methods. 2008 Nov;153(2):142-8. doi: 10.1016/j.jviromet.2008.07.013. Epub 2008 Sep 3.

PMID:
18722475
7.

Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate.

Gerdts V, Snider M, Brownlie R, Babiuk LA, Griebel PJ.

J Immunol. 2002 Feb 15;168(4):1877-85.

8.

[Immune response of preterm infants to hepatitis B vaccine administered within 24 hours after birth].

Sadeck LS, Ramos JL.

J Pediatr (Rio J). 2004 Mar-Apr;80(2):113-8. Portuguese.

9.

Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth.

Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, Parkinson AJ.

Pediatr Infect Dis J. 2005 Sep;24(9):786-92.

PMID:
16148845
10.

Benefits of early hepatitis B immunization programs for newborns and infants.

Van Herck K, Van Damme P.

Pediatr Infect Dis J. 2008 Oct;27(10):861-9. doi: 10.1097/INF.0b013e318173966f.

PMID:
18776823
11.

The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.

Xing Y, Huang Z, Lin Y, Li J, Chou TH, Lu S, Wang S.

Vaccine. 2008 Sep 19;26(40):5145-52. doi: 10.1016/j.vaccine.2008.03.072. Epub 2008 Apr 18.

PMID:
18462847
12.

[Efficacy and immune memory of plasma-derived hepatitis B vaccine 11 years after primary immunization].

Xu H, Zhuang G, Wang X, Chen Q, Chen Z.

Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar;34(2):113-5. Chinese.

PMID:
11860915
13.

Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.

Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, Bulkow L, McMahon BJ.

Vaccine. 2007 Sep 28;25(39-40):6958-64. Epub 2007 Jul 17.

PMID:
17714836
14.

Oral DNA immunization in the second trimester fetal lamb and secondary immune responses in the neonate.

Tsang CH, Mirakhur KK, Babiuk LA, Griebel PJ.

Vaccine. 2007 Dec 5;25(50):8469-79. Epub 2007 Oct 4.

PMID:
17950962
15.

Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.

Zhuang GH, Yan H, Wang XL, Hwang LY, Wu Q, Wang LR, Gao HY.

Vaccine. 2006 Mar 15;24(12):2186-92. Epub 2005 Nov 15.

PMID:
16310902
16.

Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.

Tsouchnikas I, Dounousi E, Xanthopoulou K, Papakonstantinou S, Thomoglou V, Tsakiris D.

Clin Nephrol. 2007 Oct;68(4):228-34.

PMID:
17969490
17.

Fetal immunization by a DNA vaccine delivered into the oral cavity.

Gerdts V, Babiuk LA, van Drunen Littel-van den Hurk, Griebel PJ.

Nat Med. 2000 Aug;6(8):929-32.

PMID:
10932233
18.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
19.

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device.

Roberts LK, Barr LJ, Fuller DH, McMahon CW, Leese PT, Jones S.

Vaccine. 2005 Sep 23;23(40):4867-78.

PMID:
15985318
20.

A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.

Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, Babiuk LA, Griebel PJ.

Bioelectrochemistry. 2007 May;70(2):269-74. Epub 2006 Oct 14.

PMID:
17118714

Supplemental Content

Support Center